https://www.avient.com/sites/default/files/resources/PolyOne%25202017%2520Annual%2520Report.pdf
Environmental, Health and Safety
4.
MINE SAFETY DISCLOSURES
PART II
ITEM 5.
SELECTED FINANCIAL DATA
ITEM 7.
https://www.avient.com/sites/default/files/resources/PolyOne%25202016%2520Annual%2520Report%2520Web.pdf
MINE SAFETY DISCLOSURES
Not applicable.
Environmental, Health and Safety
4.
SELECTED FINANCIAL DATA
ITEM 7.
https://www.avient.com/sites/default/files/2022-05/Avient_Health_And_Safety_Policy_2022 Update.pdf
SAFETY & HEALTH POLICY
Avient Corporation believes that safety and health are the highest corporate
priority.
As a member of the American Chemistry Council, we have
adopted Responsible Care® Guiding Principles and the Process Safety
Management Practices to continuously guide our efforts to improve safety
performance.
Our practices reinforce these imperatives, and our commitment to
excellence in safety and health is absolute.
https://www.avient.com/sites/default/files/2021-05/avnt-first-quarter-2021-earnings-presentation.pdf
Operating Income
$3,783
$4,100
2020PF 2021E
Adjusted EPS
(1) Financial information is pro forma to include a full year of Clariant Masterbatch business acquisition
Previous
Guidance
Current
Guidance
$3,783
$4,300
2020PF 2021E
$308
$360
2020PF 2021E
$308
$410
2020PF 2021E
$1.93
$2.40
2020PF 2021E
$1.93
$2.80
2020PF 2021E
(1) (1)(1)
(1)(1) (1)
(in millions) (in millions)
12
BALANCE SHEET
• Deleveraging to 1.9x net debt to
adjusted EBITDA by the end of
2021
• Driven by record adjusted EBITDA
performance and strong free cash
flow generation from asset light
business
• Future cash deployment: M&A,
opportunistic share repurchases
and balance sheet / continued
leverage reduction
3.5x
2.7x
1.9x
2019PF 2020PF 2021E
Net Debt / Adjusted EBITDA
(1) (1)
($ in m illions)
2021E Adjusted EBITDA 560$
Free Cash Flow 275$
Total Debt 1,860
Less: Cash (800)
Net Debt 1,060$
2021E Net Debt / Adjusted EBITDA 1.9x
(1) Financial information is pro forma to include a full year of Clariant Masterbatch business acquisition
S U S TA I NA B I L I T Y
• Most recent Sustainability report substantially expanded disclosure on
key environmental and social topics
D
is
t.
)
K
W
R
R
P
M
P
P
G
A
V
Y
F
U
L
G
C
P
IF
F
H
X
L
F
M
C
F
O
E
H
U
N
E
C
L
K
R
A
E
M
N
A
S
H
C
E
S
C
L
G
R
A
A
L
B
Median: 5%Median: 3%
Source: Peer data per Bloomberg market data as of April 27, 2021
Avient reflects 2021 estimated revenue of $4,300M and excludes one-time synergy capture CAPEX ($20M)
Avient Specialty
Formulators
Other
Chemical/Specialty
Companies
Free Cash Flow Conversion (1)
2021E (%)
Being asset light helps us to generate
strong free cash flow that is in line
with specialty formulators.
Free cash flow conversion calculated as (EBITDA – Capex) / EBITDA
Median: 84% Median: 77%
H I G H F R E E C A S H F L OW
C O N V E R S I O N
Avient reflects 2021 estimated EBITDA of $560M and excludes one-time synergy capture CAPEX ($20M)
Source: Peer data per Bloomberg market data as of April 27, 2021
87 89 87 86
82 81
76
88 87
84
82 81
78 77 77 77 76 73
70
69
50
19
A
vi
e
n
t
K
W
R
P
P
G
R
P
M
A
V
Y
F
U
L
G
C
P
F
M
C
IF
F
H
X
L
U
N
V
R
E
C
L
A
S
H
C
E
B
N
R
F
O
E
E
M
N
G
R
A
H
U
N
K
R
A
S
C
L
A
L
B
Source: Peer data per Bloomberg market data as of April 27, 2021
Total Enterprise Value / 2021E EBITDA
Our current valuation with updated
guidance implies an EBITDA multiple
that is below specialty formulator
peers and the majority of our
chemical peers.
https://www.avient.com/sites/default/files/2022-03/Sustainability ESG Disclosures_Animal Testing Policy.pdf
Animal Testing Policy
AVIENT CORPORATION AND SUBSIDIARIES
In the normal course of doing business, Avient is required to conduct testing to ensure the safety of its
products.
Avient is committed to replacing, reducing and refining the use of animal testing by applying the
following practices:
• Replace – Before any vertebrae testing, Avient will investigate the use of alternative methods and
approaches, including use of data that is already publically available, computational toxicology models
and read-across to available data for similar substances
Reduce – Avient will only consider animal testing if it is a legal requirement, or to ensure the safety of our
products, when no suitable alternatives are available.
https://www.avient.com/sites/default/files/2024-12/Terms and Conditions of Sale for Brazil %28English and Spanish Translation%29.pdf
Buyer acknowledges that information
in Seller’s marketing materials, technical data sheets
and other descriptive publications distributed or
published on its websites may vary from time to time
without notice.
Buyer
acknowledges that Seller has furnished to Buyer Safety
Data Sheets, which include warnings together with
safety and health information concerning the Product
and/or the containers for such Product.
Data Protection.
https://www.avient.com/sites/default/files/2024-05/Safety goggles - Application snapshot.pdf
https://www.avient.com/sites/default/files/2021-09/neu-sales-terms-and-conditions.9-16-212.pdf
Buyer acknowledges that
Seller has furnished to Buyer Safety Data Sheets, which include
warnings together with safety and health information concerning
the Product and/or the containers for such Product.
https://www.avient.com/sites/default/files/resources/PolyOne%25202014%2520Annual%2520Report.pdf
MINE SAFETY DISCLOSURES
Not applicable.
President and Chief Operating Officer, Ennis Traffic Safety
Solutions (a traffic safety and infrastructure company) from June 2008 to July 2012.
Environmental, Health and Safety
4.
https://www.avient.com/sites/default/files/2021-06/avient-ir-presentation-june-2021-w-non-gaap-recs_0.pdf
We are better together through:
Keeping Safety First — PolyOne and Clariant are both ACC Responsible Care® companies,
and nothing is more important than the health, safety and well-being of our people.
D
is
t.
)
K
W
R
R
P
M
P
P
G
A
V
Y
F
U
L
G
C
P
H
X
L
F
M
C
F
O
E
IF
F
H
U
N
E
C
L
A
S
H
E
M
N
K
R
A
C
E
S
C
L
G
R
A
A
L
B
Median: 5%Median: 3%
Source: Peer data per Bloomberg market data as of June 4, 2021
Avient reflects 2021 estimated revenue of $4,300M and excludes one-time synergy capture CAPEX ($20M)
Avient Specialty
Formulators
Other
Chemical/Specialty
Companies
Free Cash Flow Conversion (1)
2021E (%)
Being asset light helps us to generate
strong free cash flow that is in line
with specialty formulators.
Free cash flow conversion calculated as (EBITDA – Capex) / EBITDA
Median: 84% Median: 78%
H I G H F R E E C A S H F L OW
C O N V E R S I O N
Avient reflects 2021 estimated EBITDA of $560M and excludes one-time synergy capture CAPEX ($20M)
Source: Peer data per Bloomberg market data as of June 4, 2021
87
89 87 86
83 81
76
88 85 83 82 81 80 78 78 78 76
72 71 69
50
18
A
vi
e
n
t
K
W
R
P
P
G
R
P
M
A
V
Y
F
U
L
G
C
P
F
M
C
H
X
L
U
N
V
R
IF
F
E
C
L
A
S
H
F
O
E
C
E
E
M
N
B
N
R
H
U
N
G
R
A
K
R
A
S
C
L
A
L
B
Source: Peer data per Bloomberg market data as of June 4, 2021
Total Enterprise Value / 2021E EBITDA
Our current valuation with updated
guidance implies an EBITDA multiple
that is below specialty formulator
peers and the majority of our
chemical peers.